214 related articles for article (PubMed ID: 21283818)
1. Lkb1 and Pten synergise to suppress mTOR-mediated tumorigenesis and epithelial-mesenchymal transition in the mouse bladder.
Shorning BY; Griffiths D; Clarke AR
PLoS One; 2011 Jan; 6(1):e16209. PubMed ID: 21283818
[TBL] [Abstract][Full Text] [Related]
2. Important role of the LKB1-AMPK pathway in suppressing tumorigenesis in PTEN-deficient mice.
Huang X; Wullschleger S; Shpiro N; McGuire VA; Sakamoto K; Woods YL; McBurnie W; Fleming S; Alessi DR
Biochem J; 2008 Jun; 412(2):211-21. PubMed ID: 18387000
[TBL] [Abstract][Full Text] [Related]
3. Effect of PI3K- and mTOR-specific inhibitors on spontaneous B-cell follicular lymphomas in PTEN/LKB1-deficient mice.
García-Martínez JM; Wullschleger S; Preston G; Guichard S; Fleming S; Alessi DR; Duce SL
Br J Cancer; 2011 Mar; 104(7):1116-25. PubMed ID: 21407213
[TBL] [Abstract][Full Text] [Related]
4. PTEN and LKB1 are differentially required in Gli1-expressing mesenchymal cells to suppress gastrointestinal polyposis.
Cotton JL; Dang K; Hu L; Sun Y; Singh A; Rajurkar MS; Li Q; Wu X; Mao J
Cell Rep; 2022 Jul; 40(3):111125. PubMed ID: 35858546
[TBL] [Abstract][Full Text] [Related]
5. PI3K/Akt/mTOR signaling & its regulator tumour suppressor genes
Makker A; Goel MM; Mahdi AA; Bhatia V; Das V; Agarwal A; Pandey A
Indian J Med Res; 2016 May; 143(Supplement):S112-S119. PubMed ID: 27748285
[TBL] [Abstract][Full Text] [Related]
6. A genetic mouse model of invasive endometrial cancer driven by concurrent loss of Pten and Lkb1 Is highly responsive to mTOR inhibition.
Cheng H; Liu P; Zhang F; Xu E; Symonds L; Ohlson CE; Bronson RT; Maira SM; Di Tomaso E; Li J; Myers AP; Cantley LC; Mills GB; Zhao JJ
Cancer Res; 2014 Jan; 74(1):15-23. PubMed ID: 24322983
[TBL] [Abstract][Full Text] [Related]
7. AMPK/TSC2/mTOR-signaling intermediates are not necessary for LKB1-mediated nuclear retention of PTEN tumor suppressor.
Liu JL; Mao Z; Gallick GE; Yung WK
Neuro Oncol; 2011 Feb; 13(2):184-94. PubMed ID: 21123367
[TBL] [Abstract][Full Text] [Related]
8. Electric field-induced suppression of PTEN drives epithelial-to-mesenchymal transition via mTORC1 activation.
Yan T; Jiang X; Guo X; Chen W; Tang D; Zhang J; Zhang X; Zhang D; Zhang Q; Jia J; Huang Y
J Dermatol Sci; 2017 Feb; 85(2):96-105. PubMed ID: 27919618
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of integrin-linked kinase inhibits epithelial-to-mesenchymal transition and metastasis in bladder cancer cells.
Zhu J; Pan X; Zhang Z; Gao J; Zhang L; Chen J
Cell Signal; 2012 Jun; 24(6):1323-32. PubMed ID: 22570869
[TBL] [Abstract][Full Text] [Related]
10. Depletion of SAG/RBX2 E3 ubiquitin ligase suppresses prostate tumorigenesis via inactivation of the PI3K/AKT/mTOR axis.
Tan M; Xu J; Siddiqui J; Feng F; Sun Y
Mol Cancer; 2016 Dec; 15(1):81. PubMed ID: 27955654
[TBL] [Abstract][Full Text] [Related]
11. β-Catenin activation synergizes with PTEN loss to cause bladder cancer formation.
Ahmad I; Morton JP; Singh LB; Radulescu SM; Ridgway RA; Patel S; Woodgett J; Winton DJ; Taketo MM; Wu XR; Leung HY; Sansom OJ
Oncogene; 2011 Jan; 30(2):178-89. PubMed ID: 20818428
[TBL] [Abstract][Full Text] [Related]
12. Loss of LKB1 and PTEN tumor suppressor genes in the ovarian surface epithelium induces papillary serous ovarian cancer.
Tanwar PS; Mohapatra G; Chiang S; Engler DA; Zhang L; Kaneko-Tarui T; Ohguchi Y; Birrer MJ; Teixeira JM
Carcinogenesis; 2014 Mar; 35(3):546-53. PubMed ID: 24170201
[TBL] [Abstract][Full Text] [Related]
13. Epithelial cell adhesion molecule overexpression regulates epithelial-mesenchymal transition, stemness and metastasis of nasopharyngeal carcinoma cells via the PTEN/AKT/mTOR pathway.
Wang MH; Sun R; Zhou XM; Zhang MY; Lu JB; Yang Y; Zeng LS; Yang XZ; Shi L; Xiao RW; Wang HY; Mai SJ
Cell Death Dis; 2018 Jan; 9(1):2. PubMed ID: 29305578
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of epithelial-mesenchymal transition in bladder cancer cells via modulation of mTOR signalling.
Iskender B; Izgi K; Hizar E; Jauch J; Arslanhan A; Yuksek EH; Canatan H
Tumour Biol; 2016 Jun; 37(6):8281-91. PubMed ID: 26718217
[TBL] [Abstract][Full Text] [Related]
15. CEP55 promotes epithelial-mesenchymal transition in renal cell carcinoma through PI3K/AKT/mTOR pathway.
Chen H; Zhu D; Zheng Z; Cai Y; Chen Z; Xie W
Clin Transl Oncol; 2019 Jul; 21(7):939-949. PubMed ID: 30607788
[TBL] [Abstract][Full Text] [Related]
16. PTEN inactivation induces epithelial-mesenchymal transition and metastasis by intranuclear translocation of β-catenin and snail/slug in non-small cell lung carcinoma cells.
Perumal E; So Youn K; Sun S; Seung-Hyun J; Suji M; Jieying L; Yeun-Jun C
Lung Cancer; 2019 Apr; 130():25-34. PubMed ID: 30885348
[TBL] [Abstract][Full Text] [Related]
17. miR-410 induces both epithelial-mesenchymal transition and radioresistance through activation of the PI3K/mTOR pathway in non-small cell lung cancer.
Yuan Y; Liao H; Pu Q; Ke X; Hu X; Ma Y; Luo X; Jiang Q; Gong Y; Wu M; Liu L; Zhu W
Signal Transduct Target Ther; 2020 Jun; 5(1):85. PubMed ID: 32528035
[TBL] [Abstract][Full Text] [Related]
18. Inactivation of p53 and Pten promotes invasive bladder cancer.
Puzio-Kuter AM; Castillo-Martin M; Kinkade CW; Wang X; Shen TH; Matos T; Shen MM; Cordon-Cardo C; Abate-Shen C
Genes Dev; 2009 Mar; 23(6):675-80. PubMed ID: 19261747
[TBL] [Abstract][Full Text] [Related]
19. Jarid2 enhances the progression of bladder cancer through regulating PTEN/AKT signaling.
Wang X; Lyu J; Ji A; Zhang Q; Liao G
Life Sci; 2019 Aug; 230():162-168. PubMed ID: 31125562
[TBL] [Abstract][Full Text] [Related]
20. A novel role of ribonuclease inhibitor in regulation of epithelial-to-mesenchymal transition and ILK signaling pathway in bladder cancer cells.
Yao X; Li D; Xiong DM; Li L; Jiang R; Chen JX
Cell Tissue Res; 2013 Sep; 353(3):409-23. PubMed ID: 23703635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]